Status:
COMPLETED
A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe
Lead Sponsor:
Bayer
Conditions:
Ophthalmology, Macular Degeneration
Eligibility:
All Genders
Brief Summary
With this follow up physician survey researcher want to collect the same data from all participants of the study using a highly structured questionnaire. The questionnaire will gather information rela...
Eligibility Criteria
Inclusion
- Has signed informed consent
- Is a licensed and practicing ophthalmologist
- Has prescribed and/or administered aflibercept to at least one patient in the past 6 months
Exclusion
- None
Key Trial Info
Start Date :
October 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 23 2020
Estimated Enrollment :
454 Patients enrolled
Trial Details
Trial ID
NCT04067583
Start Date
October 8 2019
End Date
April 23 2020
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many locations
Multiple Locations, Germany